New approaches to understanding influenza may uncover novel therapies

July 5, 2013, Seattle Biomedical Research Institute

The influenza virus' ability to mutate quickly has produced new, emerging strains that make drug discovery more critical than ever. For the first time, researchers at Seattle BioMed, along with collaborators at the University of California, San Diego School of Medicine, St. Jude Children's Research Hospital and the University of Washington, have mapped how critical molecules regulate both the induction and resolution of inflammation during flu infection. The results are published this month in the journal Cell.

Flu is an elusive foe

The mutates extremely quickly, with different strains causing seasonal epidemics each year. Genetic shuffling between different viruses can increase influenza's ability to spread, causing devastating epidemics and pandemics. The 1918 , the first to involve the H1N1 strain, cost the lives of 50 to 100 million people, and even a typical can cost as many as 50,000 lives a year.

Vaccines are a highly effective way to combat the , but because manufacturing and distributing vaccines takes such a long time, it is impossible for to wait until they know for certain which strain of flu will prevail in a given season. "Because of this, drugs are critically important to combat ," says Alan Aderem, Ph.D., principal investigator on the research. "But at the moment, we have very few drugs at our disposal, and resistance is already beginning to appear against our limited arsenal."

Systems biology yielding new insights

The solution for Aderem and scientist Vincent Tam, Ph.D., was to take a systems approach to better understand the interactions between the and the . They teamed up with Oswald Quehenberger, Ph.D., and Edward Dennis, Ph.D., of the University of California, San Diego School of Medicine to tackle this problem. Systems biology uses to integrate the study of genes, proteins and lipids. This comprehensive approach unravels the complexities and provides a holistic view of the host-pathogen interaction. This strategy, focusing on lipid components, had never before been applied to the flu infection.

There is a class of lipid mediators that act as signaling molecules to control inflammation, and have long been known to play a role in stimulating an inflammatory response. "But some of these regulatory lipids, including ones derived from the omega-3 fatty acids and known as DHA and EPA, are also involved in resolving inflammation and bringing the body back to homeostasis," observed Quehenberger and Dennis. This dual role makes lipid mediators a critical player in the interaction between the virus and the human immune system.

The research team studied 141 different lipid metabolites and incorporated them into networks comprising lipids, genes and proteins of host responses to two different strains of the flu virus, one mild and one severe. In doing so, they found that infection by the mild H3N2 strain induced a pro-inflammatory response followed by a distinct anti-inflammatory response. This represented a case of a clearly regulated inflammatory response. In contrast, infection by the severe H1N1 strain resulted in overlapping pro- and anti-inflammatory states, indicating that the virus had disturbed the normal methods of controlling inflammation.

Importantly, the study discovered that many of the results found in the mouse model were recapitulated in humans by studying nasal wash samples collected from flu-infected patients. "It is absolutely crucial to confirm the relevance of these molecules in humans if we want to look for effective therapeutics against flu," says Aderem.

Moving to new interventions

"Once an infection starts, it's too late for vaccines," says Dennis, explaining the urgent need for drugs to combat the influenza virus. Emerging strains like H5N1 and H7N9—more commonly known as bird flu—are especially dangerous, killing about 60% of the people they infect, according to data from the Centers for Disease Control and Prevention. Because drugs fight infections that are already underway, they are a critical player in keeping the multitude of flu strains under control.

A more complete understanding of how the flu virus interacts with the human immune system, including the role of lipid mediators, could reveal important new drug targets. "If we can perturb the balance between pro- and anti-inflammatory responses in flu patients, we can help them regulate their immune systems to control their infections," says Tam.

Explore further: New research finds flu shot effective regardless of circulating flu strain

Related Stories

New research finds flu shot effective regardless of circulating flu strain

June 25, 2013
New research out of St. Michael's Hospital has found that despite popular belief, the flu shot is effective in preventing the flu, even if the virus going around does not match the vaccine.

Researchers suggest boosting body's natural flu killers

May 23, 2013
A known difficulty in fighting influenza (flu) is the ability of the flu viruses to mutate and thus evade various medications that were previously found to be effective. Researchers at the Hebrew University of Jerusalem have ...

Bird flu expert working on vaccine that protects against multiple strains

May 10, 2013
(Medical Xpress)—As the bird flu outbreak in China worsens, a Purdue University expert is working on vaccines that offer broader protection against multiple strains of the virus.

New flu strains prompt review of current research, call to redouble flu fight

May 30, 2013
Despite numerous medical advances over the past century, the flu—a seasonal rite of passage for many around the world—still remains deadly and dangerous. An estimated 150,000 to 200,000 are hospitalized from influenza ...

Gene discovery helps explain how flu can cause severe infections

June 28, 2012
Scientists have discovered a new gene in the influenza virus that helps the virus control the body's response to infection.

Researchers develop universal flu vaccine: New technology could become available to consumers within a decade

April 3, 2013
(Medical Xpress)—Flu is unpredictable. Influenza viruses are constantly changing—from one season to the next or even within the course of a flu season—making vaccine development difficult.

Recommended for you

Fresh approach to tuberculosis vaccine offers better protection

January 17, 2018
A unique platform that resulted in a promising HIV vaccine has also led to a new, highly effective vaccine against tuberculosis that is moving toward testing in humans.

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

New study validates clotting risk factors in chronic kidney disease

January 17, 2018
In late 2017, researchers from Boston University School of Medicine (BUSM) discovered and published (Science Translational Medicine, (9) 417, Nov 2017) a potential treatment target to prevent chronic kidney disease (CKD) ...

Newly-discovered TB blood signal provides early warning for at-risk patients

January 17, 2018
Tuberculosis can be detected in people with HIV infection via a unique blood signal before symptoms appear, according to a new study by researchers from the Crick, Imperial College London and the University of Cape Town.

New study offers insights on genetic indicators of COPD risk

January 16, 2018
Researchers have discovered that genetic variations in the anatomy of the lungs could serve as indicators to help identify people who have low, but stable, lung function early in life, and those who are particularly at risk ...

Previous influenza virus exposures enhance susceptibility in another influenza pandemic

January 16, 2018
While past exposure to influenza A viruses often builds immunity to similar, and sometimes different, strains of the virus, Canadian researchers are calling for more attention to exceptions to that rule.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.